echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nat Commun: "Enhanced subcapajaja" event determines the structure of ecDNA MYCN amplification in neuroblastoma

    Nat Commun: "Enhanced subcapajaja" event determines the structure of ecDNA MYCN amplification in neuroblastoma

    • Last Update: 2020-12-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The amplification of cancer genes is a marker of the cancer genome, which can lead to the overexplification of primary cancer genes and is a key driver of carcinogenic effects.
    studies have shown that there are two main forms of redundant gene copies: (i) self-repeating arrays on chromosomes (homogeneity chromosomal regions, HSRs) and (ii) many independent ring DNA molecules (chromosome outer ring DNA, ecDNA).
    ecDNA may be produced and amplified in genome recombination events such as chromothripsis.
    ecDNA re-integration into chromosomes can lead to amplification in chromosomes and act as a driving force for genomic remodeling.
    , however, little is known about the function of the non-coding areas that are co-amplified in ecDNA.
    has identified five specific enhancers in neuroblastoma cells that express MYCN, and previous studies have shown that amplification of the MYCN gene is a driving force behind one in six neuroblastomas.
    are usually found on highly rearmed ecDNA.
    so far, the exact amplification substruct and its rearfuration function have not been clear.
    the study, the researchers analyzed the structure of myCN amplifier using short-read sequencing and nanopore sequencing techniques, and analyzed its chromatin spectrometry using ChIP-seq, ATAC-seq, and Hi-C.
    two types of MYCN amplifications can be found in neuroblastoma to reveal two different types of amplifications to explain the regulation of MYCN over-expression.
    researchers found that the first class of amplifications was always amplified together with near-end enhancers driven by CRC (the epinephrine regulatory circuit).
    second class of MYCN amplifier manifests itself as a highly complex structure, lacking critical in-place enhancers, and instead containing far-end chromosome fragments with CRC-driven enhancers.
    enhancer co-amplification determines the pattern of MYCN amplifier in general, and this study shows that heterogeneity enhancer hijacking compensates for the in-place absence of gene regulatory elements, and this finding also provides a major explanation for the structural diversity observed during MYCN amplification.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.